Rivacor 7 HF-T QP/HF-T

Acticor CRT-Ds have an extended battery life of 9 years⁹, supported by a full 6-year warranty.

• Acticor CRT-Ds live up to 9 years and are the smallest, slimmest 3T FBS devices that live that long¹⁰
• Extended warranty reduces financial risk for implanting clinics, as fewer devices for replacement procedures will need to be purchased

This can lead to fewer box replacements and fewer procedures for patients, reducing risks, complications and costs.

• For CRT patients, who already face a higher risk burden, increased device longevity can reduce the number of replacements. These patients are exposed to higher risk of complication than single- or dual-chamber ICD patients¹¹
• Saving a replacement can lead to lower risk and less distress for CRT patients
• Fewer replacements means reduced procedure costs. At the same time, complication-related costs can be avoided by reducing risks resulting from replacements

Acticor 7 CRT-D features CRT AutoAdapt:

• Every minute, CRT AutoAdapt automatically adjusts to changes in the patient’s condition, thus providing continuous CRT adaptation and allowing for more personalized response.
• Automatic AV delay optimization focus on clinically relevant intrinsic timing.
• Automatic selection of paced chambers based on A-RV and A-LV conduction patterns.
• By reducing pacing to LV-only, battery life can reach up to 10.8 years, even with daily remote data transmission12

Heart failure is a serious and progressive condition that puts CRT patients at risk in multiple ways. For these patients, AF is a common cause for loss of CRT pacing, while hospitalization for decompensation is a frequent concern. Therefore, clinical guidelines recommend close multiparameter monitoring, because time is of the essence.

When CRT-Ds are used with BIOTRONIK Home Monitoring, life can be further prolonged with a clinically-proven > 60% reduction in all-cause mortality¹⁴.

• Early detection of clinically relevant events through BIOTRONIK Home Monitoring enables early intervention¹⁵
• The IN-TIME trial shows that all-cause mortality can be reduced by >60%16. This outcome can be achieved by following the IN-TIME protocol, based on daily transmissions
• BIOTRONIK Home Monitoring can be easily programmed to IN-TIME settings, enabling 28 alerts with the click of a button. This avoids the hassle of manually adjusting the alert settings to trigger ‘IN-TIME events’

Home Monitoring works via a smartphone-size, ‘plug in and go’ CardioMessenger Smart mobile unit, which is quick and easy to use¹⁷ and transmits data without any patient involvement.

• BIOTRONIK's 'plug in and go' solution allows for user-friendly system initialization. Data transmission is completely automatic, not requiring any active patient involvement¹⁸, while the smartphone-sized CardioMessenger Smart transmitter makes BIOTRONIK Home Monitoring a mobile system.
• Daily, system-based transmission checks allow for industry-leading transmission success rates of 85%^19,20
• 99% of patients agree that BIOTRONIK Home Monitoring is easy to use, while 98% express their complete satisfaction with the system²¹

QuickCheck gives access to patient data typically within 3 to 4 minutes²² for more efficient treatment and greater peace of mind for patients.

• QuickCheck provides fast access to patient data. Upon the physician’s request in the Home Monitoring Service Center, data typically becomes available within 3 to 4 minutes²³
• Patient device data can be transmitted without patient interaction
• This allows clinicians to be responsive to patients' needs remotely, while patient satisfaction may be positively influenced by the knowledge that the physician has access to current cardiac device data
• Immediate clarification and patient reassurance might be complemented by a scheduled visit (for instance, on the next day), reducing the need for spontaneous hospital visits